Practice Competition and Treatment of Newly Diagnosed Prostate Cancer.
暂无分享,去创建一个
V. Shahinian | B. Hollenbeck | S. Kaufman | A. Maganty | L. Lai | M. Oerline | M. Caram | Megan E. V. Caram
[1] M. Furukawa,et al. Consolidation Of Providers Into Health Systems Increased Substantially, 2016-18. , 2020, Health affairs.
[2] G. Deeb,et al. The Effect of Hospital Market Competition on the Adoption of Transcatheter Aortic Valve Replacement. , 2020, The Annals of thoracic surgery.
[3] Leemore S. Dafny,et al. Changes in Quality of Care after Hospital Mergers and Acquisitions. , 2020, The New England journal of medicine.
[4] T. Skolarus,et al. Practice-Level Adoption of Conservative Management for Prostate Cancer. , 2019, Journal of oncology practice.
[5] J. Mohler,et al. NCCN Guidelines Updates: Management of Prostate Cancer. , 2019, Journal of the National Comprehensive Cancer Network : JNCCN.
[6] Andrew S. Boozary,et al. The Association Between Hospital Concentration And Insurance Premiums In ACA Marketplaces. , 2019, Health affairs.
[7] J. Van Reenen,et al. THE PRICE AIN'T RIGHT? HOSPITAL PRICES AND HEALTH SPENDING ON THE PRIVATELY INSURED. , 2018, The quarterly journal of economics.
[8] David C. Miller,et al. Variation in prostate cancer treatment and spending among Medicare shared savings program accountable care organizations , 2018, Cancer.
[9] Ronald C. Chen,et al. Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care Options , 2018, The Journal of urology.
[10] David C. Miller,et al. Early effect of Medicare Shared Savings Program accountable care organization participation on prostate cancer care , 2018, Cancer.
[11] T. Skolarus,et al. Urologist Practice Affiliation and Intensity-modulated Radiation Therapy for Prostate Cancer in the Elderly. , 2017, European urology.
[12] A. Mehrotra,et al. High-Price And Low-Price Physician Practices Do Not Differ Significantly On Care Quality Or Efficiency. , 2017, Health affairs.
[13] David Gillatt,et al. 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer. , 2017, The New England journal of medicine.
[14] Issa J Dahabreh,et al. Using group data to treat individuals: understanding heterogeneous treatment effects in the age of precision medicine and patient-centred evidence. , 2016, International journal of epidemiology.
[15] D. Muhlestein,et al. Physician Consolidation: Rapid Movement From Small To Large Group Practices, 2013-15. , 2016, Health affairs.
[16] S. Parente,et al. Prices For Common Medical Services Vary Substantially Among The Commercially Insured. , 2016, Health affairs.
[17] L. Baker,et al. Physician practice competition and prices paid by private insurers for office visits. , 2014, JAMA.
[18] T. Tammela,et al. Overdiagnosis and overtreatment of prostate cancer. , 2014, European Urology.
[19] Abe Dunn,et al. Do Physicians Possess Market Power? , 2014, The Journal of Law and Economics.
[20] D. Contandriopoulos,et al. Fee increases and target income hypothesis: data from Quebec on physicians' compensation and service volumes. , 2013, Healthcare Policy | Politiques de Santé.
[21] David M Cutler,et al. Hospitals, market share, and consolidation. , 2013, JAMA.
[22] John T. Wei,et al. Use of advanced treatment technologies among men at low risk of dying from prostate cancer. , 2013, JAMA.
[23] Y. Kuo,et al. Reimbursement policy and androgen-deprivation therapy for prostate cancer. , 2010, The New England journal of medicine.
[24] M. Tinetti,et al. The Effect of Age and Chronic Illness on Life Expectancy after a Diagnosis of Colorectal Cancer: Implications for Screening , 2006, Annals of Internal Medicine.
[25] M. Gaynor,et al. Increasing consolidation in healthcare markets: what are the antitrust policy implications? , 1998, Health services research.
[26] M. Chernew,et al. Market Share Matters: Evidence Of Insurer And Provider Bargaining Over Prices. , 2017, Health affairs.